Journal of Clinical Hypertension

Papers
(The H4-Index of Journal of Clinical Hypertension is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Construction and validation of a nomogram to predict left ventricular hypertrophy in low‐risk patients with hypertension825635384
Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmato805909040
Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension72
COVID‐19 and arterial hypertension: Hypothesis or evidence?59
COVID‐19 and diabetes: Is there enough evidence?57
Hypertension and stroke in Asia: A comprehensive review from HOPE Asia48
Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID‐19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hos45
The slowdown in the reduction rate of premature mortality from cardiovascular diseases puts the Americas at risk of achieving SDG 3.4: A population trend analysis of 37 countries from 1990 to 201739
COVID‐19 and hypertension—evidence and practical management: Guidance from the HOPE Asia Network39
Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk38
Non‐pharmacological management of hypertension38
Standardized treatment to improve hypertension control in primary health care: The HEARTS in the Americas Initiative35
Association of triglyceride glucose index and its combination of obesity indices with prehypertension in lean individuals: A cross‐sectional study of Chinese adults35
How to check whether a blood pressure monitor has been properly validated for accuracy35
Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: A systematic analysis of current evidence34
India Hypertension Control Initiative—Hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics33
Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: A systematic review and meta‐analysis33
The prognostic role of serum uric acid levels in preeclampsia: A meta‐analysis32
Use of distinct anti‐hypertensive drugs and risk for COVID‐19 among hypertensive people: A population‐based cohort study in Southern Catalonia, Spain31
Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network31
Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring30
Wide pulse pressure: A clinical review29
The association of triglyceride and glucose index, and triglyceride to high‐density lipoprotein cholesterol ratio with prehypertension and hypertension in normoglycemic subjects: A large cross‐section28
Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR study27
Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network26
Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study26
Myocardial work in hypertensive patients with and without diabetes: An echocardiographic study26
0.075811147689819